Your session is about to expire
← Back to Search
Transitional Care Program for HIV, Hepatitis C, and Substance Use Disorders (CJC-TraC Trial)
N/A
Waitlist Available
Led By Ryan Westergaard, MD, PhD, MPH
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 3-months following release (up to 6 months on study)
Awards & highlights
CJC-TraC Trial Summary
This trialwill test a medical program to help 220 ex-prisoners with HIV, HCV, or substance abuse. Results will be monitored for up to 6 months. #medical #prisoners #HIV #HCV #substanceabuse
Who is the study for?
This trial is for incarcerated individuals in Wisconsin who are eligible for Medicaid and will be released within 6 months. They must understand English, plan to stay in Wisconsin post-release, and have HIV, Hepatitis C or a history of substance misuse.Check my eligibility
What is being tested?
The study tests the Coordinated Transitional Care intervention (CJC-TraC) adapted for those transitioning from incarceration back into society. It focuses on people with HIV, Hepatitis C or substance use disorders over a period of up to 6 months.See study design
What are the potential side effects?
Since this trial involves a care coordination intervention rather than medication, traditional side effects are not applicable. However, participants may experience stress or anxiety related to the transition process.
CJC-TraC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 3-months following release (up to 6 months on study)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 3-months following release (up to 6 months on study)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability assessed by subjective experience of the Participant (Qualitative Measure)
Acceptability measured by the Proportion of Department of Corrections (DOC) staff who rated the intervention acceptable, useful, or appropriate
Acceptability measured by the Proportion of study participants who rated specific aspects of the intervention useful and encounter volumes appropriate
+4 moreSecondary outcome measures
Number days until the first non-emergency outpatient visit following release.
Number of non-emergency outpatient visits observed within 3-months following release
CJC-TraC Trial Design
1Treatment groups
Experimental Treatment
Group I: CJC-TraC InterventionExperimental Treatment1 Intervention
Incarcerated individuals with HIV, hepatitis C, or substance use disorder readying for release will enroll in the CJC-TraC intervention intended to assist in transitioning their health care.
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,413 Total Patients Enrolled
46 Trials studying Hepatitis C
22,318 Patients Enrolled for Hepatitis C
University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,167,167 Total Patients Enrolled
4 Trials studying Hepatitis C
638 Patients Enrolled for Hepatitis C
Ryan Westergaard, MD, PhD, MPHPrincipal InvestigatorUW School of Medicine and Public Health
2 Previous Clinical Trials
549 Total Patients Enrolled
1 Trials studying Hepatitis C
341 Patients Enrolled for Hepatitis C
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am able to understand and make decisions about my health care.You have either HIV, Hepatitis C or have been identified as needing substance use treatment based on an assessment.
Research Study Groups:
This trial has the following groups:- Group 1: CJC-TraC Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available openings for participants to join this research?
"As per the information on clinicaltrials.gov, this trial is not actively enrolling patients at present. The study was first made public on November 29 2022 and has since been edited as of December 1st 2022 without any new additions. However, there are 869 other medical investigations that are currently seeking out participants to join their research team."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger